Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups
about
sameAs
Oral antiplatelet therapy for acute ischaemic strokeMultiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attackAntiplatelet therapy for acute ischaemic strokeAntiplatelet therapy for acute ischaemic strokeCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsUnderutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.Aspirin in the prevention of progressing stroke: a randomized controlled studyC-reactive protein, cardiovascular disease and stroke: new roles for an old biomarkerTiming of aspirin and secondary preventative therapies in acute stroke: support for use of stroke unitsLack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in ratsLink between platelet activity and outcomes after an ischemic strokeStroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?New treatments in acute ischemic strokeThe use of neurovascular imaging for triaging TIA and minor stroke: implications for therapyPlatelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of strokeAntithrombotic agents' use in patients with atrial fibrillation and acute cerebral ischemiaChanging attitudes to the management of ischaemic stroke between 1997 and 2004: a survey of New Zealand physiciansTowards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Use of aspirin in acute strokeDose of aspirin in the treatment and prevention of cardiovascular disease: current and future directionsPrevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articlesRole of heparin and low-molecular-weight heparins in the management of acute ischemic strokeDuration of hospital participation in a nationwide stroke registry is associated with improved quality of careEvaluation of a service development to implement the top three process indicators for quality stroke careKnowledge of risk factors and warning signs of strokeAntithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.Cross-sectional analysis of data from the U.S. clinical trials database reveals poor translational clinical trial effort for traumatic brain injury, compared with stroke.Reviews of individual patient data (IPD) are useful for geriatrics: an overview of available IPD reviews.Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.Prevention of ischaemic stroke.Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry.Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot StudyStroke management.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represAspirin for acute stroke of unknown etiology in resource-limited settings: a decision analysis.Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings.Radiology of stroke.Medical management of stroke.Transient ischaemic attack (TIA) knowledge in general practice: a cross-sectional study of Western Adelaide general practitionersDual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier?
P2860
Q24197866-80BB8E07-F45D-4DCE-9A27-0FBBD316DAF1Q24201386-D8FE21D8-F4E8-4A5A-801C-C93EFC007BDCQ24242725-BEB23E27-1ED2-4392-BC03-323C6C55A738Q24248787-978CFF08-E02A-42F7-8F92-277336E83A1FQ24555072-EC29EE89-482B-40E2-9553-6DB9516B50DEQ24816911-44AD641F-2359-4FBF-B515-A1931462B5BBQ28166278-6430FB49-D13C-4A6D-95C7-5C74D703855EQ28174368-E6445441-5D3A-4863-9AC4-49ADE235F460Q28181786-06D0957F-F857-48F9-A82C-6011DA1E1F32Q28181824-B391FA33-FDBC-493B-B0E6-02683D2016CEQ28183244-A94F30C0-7774-4564-9A5B-6FBC6D295AF3Q28189131-6B07BFB6-BB4C-4136-9694-C4A581F14AD3Q28192644-5F00446F-B055-4A5D-8C97-8EE31CB2423EQ28196724-774BB3F8-020E-4178-B428-3B9DD6FEC8E4Q28196726-7ECC5272-5644-4879-960C-BF2D788EA20AQ28196922-CB5B4E53-3939-405B-9C22-759ECACFD099Q28196935-ADEC1920-6E47-4C71-A858-BC5ED1F43C92Q28200514-76408C5B-0F62-4707-B166-287173745910Q28200895-6872A216-8BAC-4B9A-8DBC-69DC5487216AQ28217686-D006F5E5-9715-4939-8E3F-162DD325214EQ28218271-CB94531F-53BE-473F-A914-0C26552602E1Q28218671-AAB21DE3-F5F6-45C5-A4E1-70C43C986CBBQ28218793-BE979ED0-6C37-4037-83E0-4604EEEFEC52Q28219244-198CE6F1-29FB-4A46-9AFE-2C3C616F724DQ30484358-4C8A395F-340B-42C8-80D5-AF33CD69E402Q30541348-6B91C2BA-20BE-4BAD-9278-7CB5A0E88651Q30731729-472B1441-C079-47AF-B54C-55145369FB9FQ30815345-854196DB-C0D1-4574-8913-F900CBB379F6Q31016826-A205E242-912E-411B-9073-FDA098BF195FQ33803258-5C0EF115-8603-4991-90BF-36874A3147DBQ33863255-8B589185-7A8C-4DBB-A201-AA44D6DFE921Q33874668-3D3D8C88-ABEE-4550-990C-808409B59D31Q33928297-9A986A49-0B58-47FC-B5C7-99E1B05CD346Q34046881-F2F71BF0-A4A3-45FB-9097-CFAA1FEA5E78Q34135718-9054BD25-2960-4822-8A60-50C98A19C4D0Q34170991-8F1F0C68-CD4C-4EBB-8765-A855B2EFF11CQ34187203-6B1235A7-71DC-4836-8A62-055DF7A14407Q34187207-BE31C7D0-4D40-43B2-94EC-565F2D9E5C01Q34296397-3D68CD0E-129D-4B51-A551-BFAA751F2D15Q34479105-28B5C324-5D36-4BF9-B01D-E79FC0E53640
P2860
Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Indications for early aspirin ...... T and IST collaborative groups
@ast
Indications for early aspirin ...... T and IST collaborative groups
@en
Indications for early aspirin ...... T and IST collaborative groups
@nl
type
label
Indications for early aspirin ...... T and IST collaborative groups
@ast
Indications for early aspirin ...... T and IST collaborative groups
@en
Indications for early aspirin ...... T and IST collaborative groups
@nl
prefLabel
Indications for early aspirin ...... T and IST collaborative groups
@ast
Indications for early aspirin ...... T and IST collaborative groups
@en
Indications for early aspirin ...... T and IST collaborative groups
@nl
P2093
P921
P3181
P356
P1433
P1476
Indications for early aspirin ...... T and IST collaborative groups
@en
P2093
C Counsell
P Sandercock
P304
P3181
P356
10.1161/01.STR.31.6.1240
P407
P577
2000-06-01T00:00:00Z